Oric Pharmaceuticals IncNASDAQ:ORIC
- LAST PRICE10.7300
- TODAY'S CHANGE (%)-0.5200 (-4.6222%)
- Bid / Lots10.7400/ 10
- Ask / Lots11.5000/ 2
- Open / Previous Close11.3000 / 11.2500
- Day Range
- 52 Week Range
- Volume606,157
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORIC |
|---|---|---|
| 09:32 ET | 15211 | 11.53 |
| 09:34 ET | 746 | 11.355 |
| 09:36 ET | 1400 | 11.4 |
| 09:39 ET | 1075 | 11.19 |
| 09:41 ET | 1766 | 11.13 |
| 09:43 ET | 200 | 11.145 |
| 09:45 ET | 3124 | 11.05 |
| 09:48 ET | 3718 | 11.05 |
| 09:50 ET | 300 | 11.06 |
| 09:52 ET | 4228 | 11.125 |
| 09:54 ET | 10575 | 11.15 |
| 09:56 ET | 300 | 11.25 |
| 09:57 ET | 100 | 11.26 |
| 09:59 ET | 11025 | 11.2 |
| 10:01 ET | 958 | 11.28 |
| 10:03 ET | 2090 | 11.22 |
| 10:06 ET | 400 | 11.2 |
| 10:12 ET | 100 | 11.26 |
| 10:14 ET | 2090 | 11.235 |
| 10:15 ET | 2272 | 11.18 |
| 10:17 ET | 4143 | 11.18 |
| 10:19 ET | 4053 | 11.165 |
| 10:21 ET | 4913 | 11.155 |
| 10:26 ET | 4257 | 11.14 |
| 10:28 ET | 26415 | 11.22 |
| 10:30 ET | 300 | 11.17 |
| 10:32 ET | 693 | 11.18 |
| 10:33 ET | 369 | 11.172 |
| 10:35 ET | 257 | 11.17 |
| 10:37 ET | 3146 | 11.16 |
| 10:39 ET | 2588 | 11.18 |
| 10:42 ET | 600 | 11.175 |
| 10:44 ET | 458 | 11.23 |
| 10:46 ET | 100 | 11.2 |
| 10:48 ET | 200 | 11.22 |
| 10:50 ET | 10834 | 11.19 |
| 10:51 ET | 1901 | 11.1 |
| 10:53 ET | 110 | 11.13 |
| 10:55 ET | 200 | 11.11 |
| 11:00 ET | 100 | 11.08 |
| 11:02 ET | 848 | 11.08 |
| 11:04 ET | 600 | 11.02 |
| 11:06 ET | 2652 | 10.98 |
| 11:08 ET | 300 | 10.96 |
| 11:09 ET | 807 | 10.95 |
| 11:11 ET | 2113 | 10.97 |
| 11:13 ET | 809 | 10.985 |
| 11:15 ET | 1543 | 10.975 |
| 11:18 ET | 2550 | 11.02 |
| 11:20 ET | 600 | 10.97 |
| 11:22 ET | 100 | 10.96 |
| 11:24 ET | 100 | 10.96 |
| 11:26 ET | 1546 | 10.98 |
| 11:27 ET | 4050 | 10.9825 |
| 11:29 ET | 3618 | 10.99 |
| 11:31 ET | 1492 | 10.97 |
| 11:33 ET | 4191 | 10.96 |
| 11:36 ET | 4251 | 10.96 |
| 11:38 ET | 300 | 10.95 |
| 11:40 ET | 837 | 10.99 |
| 11:42 ET | 1955 | 11.035 |
| 11:44 ET | 100 | 11.01 |
| 11:45 ET | 200 | 11.02 |
| 11:47 ET | 100 | 11.04 |
| 11:49 ET | 881 | 11.06 |
| 11:51 ET | 300 | 11.1 |
| 11:54 ET | 1038 | 11.14 |
| 11:56 ET | 1250 | 11.2 |
| 12:00 ET | 100 | 11.22 |
| 12:02 ET | 400 | 11.19 |
| 12:05 ET | 390 | 11.1503 |
| 12:07 ET | 100 | 11.18 |
| 12:09 ET | 900 | 11.19 |
| 12:14 ET | 1419 | 11.17 |
| 12:16 ET | 1944 | 11.17 |
| 12:18 ET | 4921 | 11.16 |
| 12:20 ET | 7209 | 11.15 |
| 12:21 ET | 335 | 11.16 |
| 12:23 ET | 10522 | 11.0601 |
| 12:25 ET | 100 | 11.07 |
| 12:27 ET | 500 | 11.07 |
| 12:34 ET | 1253 | 11.005 |
| 12:36 ET | 600 | 11.02 |
| 12:38 ET | 1946 | 10.985 |
| 12:39 ET | 2420 | 11.01 |
| 12:43 ET | 1156 | 11.03 |
| 12:45 ET | 277 | 11.05 |
| 12:48 ET | 575 | 11.055 |
| 12:52 ET | 718 | 11.1 |
| 12:54 ET | 700 | 11.05 |
| 12:57 ET | 2764 | 11.025 |
| 12:59 ET | 963 | 11.025 |
| 01:01 ET | 1100 | 11 |
| 01:03 ET | 200 | 11.015 |
| 01:06 ET | 600 | 11.01 |
| 01:10 ET | 8800 | 11.005 |
| 01:12 ET | 4723 | 10.98 |
| 01:14 ET | 100 | 10.98 |
| 01:15 ET | 300 | 10.985 |
| 01:17 ET | 100 | 10.985 |
| 01:19 ET | 400 | 10.985 |
| 01:21 ET | 1592 | 10.985 |
| 01:24 ET | 1400 | 10.935 |
| 01:26 ET | 4648 | 10.915 |
| 01:28 ET | 9565 | 10.89 |
| 01:30 ET | 4170 | 10.865 |
| 01:33 ET | 982 | 10.78 |
| 01:35 ET | 2663 | 10.79 |
| 01:37 ET | 3383 | 10.76 |
| 01:39 ET | 801 | 10.73 |
| 01:44 ET | 2308 | 10.76 |
| 01:48 ET | 400 | 10.765 |
| 01:50 ET | 4545 | 10.72 |
| 01:51 ET | 348 | 10.71 |
| 01:53 ET | 1100 | 10.775 |
| 01:55 ET | 200 | 10.78 |
| 01:57 ET | 200 | 10.77 |
| 02:00 ET | 1100 | 10.77 |
| 02:02 ET | 338 | 10.77 |
| 02:04 ET | 180 | 10.75 |
| 02:06 ET | 335 | 10.76 |
| 02:08 ET | 602 | 10.8 |
| 02:09 ET | 700 | 10.825 |
| 02:11 ET | 2384 | 10.785 |
| 02:13 ET | 5606 | 10.77 |
| 02:18 ET | 373 | 10.75 |
| 02:20 ET | 1300 | 10.76 |
| 02:22 ET | 3998 | 10.81 |
| 02:24 ET | 238 | 10.85 |
| 02:29 ET | 100 | 10.87 |
| 02:31 ET | 200 | 10.92 |
| 02:33 ET | 1100 | 10.87 |
| 02:38 ET | 433 | 10.87 |
| 02:42 ET | 253 | 10.82 |
| 02:44 ET | 1504 | 10.83 |
| 02:49 ET | 438 | 10.845 |
| 02:51 ET | 1100 | 10.85 |
| 02:54 ET | 100 | 10.84 |
| 02:56 ET | 1200 | 10.845 |
| 03:00 ET | 100 | 10.86 |
| 03:02 ET | 200 | 10.84 |
| 03:03 ET | 955 | 10.86 |
| 03:05 ET | 500 | 10.85 |
| 03:07 ET | 1700 | 10.8699 |
| 03:09 ET | 200 | 10.86 |
| 03:12 ET | 200 | 10.85 |
| 03:14 ET | 391 | 10.88 |
| 03:16 ET | 500 | 10.88 |
| 03:27 ET | 100 | 10.89 |
| 03:30 ET | 300 | 10.88 |
| 03:32 ET | 3402 | 10.89 |
| 03:34 ET | 455 | 10.895 |
| 03:36 ET | 530 | 10.895 |
| 03:38 ET | 4021 | 10.87 |
| 03:39 ET | 1800 | 10.88 |
| 03:41 ET | 975 | 10.9 |
| 03:43 ET | 504 | 10.89 |
| 03:45 ET | 1291 | 10.895 |
| 03:48 ET | 500 | 10.88 |
| 03:50 ET | 4299 | 10.86 |
| 03:52 ET | 1700 | 10.85 |
| 03:54 ET | 1506 | 10.9 |
| 03:56 ET | 2275 | 10.88 |
| 03:57 ET | 4089 | 10.84 |
| 03:59 ET | 135597 | 10.73 |
Sep 18, 2024
DJ Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 1:42PM ET on Wednesday Sep 18, 2024 by Dow Jones
1:42PM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 10, 2024
DJ Oric Pharmaceuticals Price Target Maintained With a $20.00/Share by Wedbush, from 9:08AM ET on Tuesday Sep 10, 2024 by Dow Jones
9:08AM ET on Tuesday Sep 10, 2024 by Dow Jones
Sep 6, 2024
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Sep 06, 2024 by Dow Jones
4:30PM ET on Friday Sep 06, 2024 by Dow JonesDJ Oric Pharmaceuticals Initiated at Buy by Stifel, from 11:39AM ET on Friday Sep 06, 2024 by Dow Jones
11:39AM ET on Friday Sep 06, 2024 by Dow Jones
Aug 26, 2024
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences, from 4:05PM ET on Monday Aug 26, 2024 by Dow Jones
4:05PM ET on Monday Aug 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oric Pharmaceuticals Inc | 793.6M | -6.1x | --- |
Olema Pharmaceuticals Inc | 781.1M | -6.3x | --- |
Rapport Therapeutics Inc | 776.5M | 0.0x | --- |
Erasca Inc | 816.4M | -2.8x | --- |
Arrivent Biopharma Inc | 833.3M | -9.2x | --- |
Scholar Rock Holding Corp | 751.5M | -3.9x | --- |
Company Information
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Contact Information
- Headquarters
- 240 E. Grand Ave, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-388-5600
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Heyman
- President, Chief Executive Officer, Director
- Jacob Chacko
- Chief Financial Officer
- Dominic Piscitelli
- Chief Medical Officer
- Pratik Multani
- Independent Director
- Mardi Dier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $793.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.11 |
EPS | $-1.76 |
Book Value | $4.08 |
P/E Ratio | -6.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
